Want to see JP:5592 full AI Analyst Report?
5592 Stock Chart & Stats
¥2661.00
-¥9.00(-0.63%)
At close: 4:00 PM EST
¥2661.00
-¥9.00(-0.63%)
Day’s Range― - ―
52-Week Range¥2,065.00 - ¥4,685.00
Previous CloseN/A
Volume47.70K
Average Volume (3M)73.92K
Market Cap
¥29.11B
Enterprise Value¥26.83B
Total Cash (Recent Filing)¥5.20B
Total Debt (Recent Filing)¥2.82B
Price to Earnings (P/E)9.6
Beta0.64
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.5%
Share Statistics
EPS (TTM)263.13
Shares Outstanding11,459,482
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.41
Price to Sales (P/S)2.22
P/FCF Ratio9.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)188.9
Revenue Forecast (FY)¥14.30B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue And Earnings GrowthConsistent multi-year revenue and net income expansion materially increases the company's scale and operating leverage. Durable top-line growth supports reinvestment in product and customer acquisition, strengthens margin potential, and underpins longer-term cash generation and strategic optionality.
Strengthened Equity Base And Balance-sheet ResilienceA much larger equity cushion materially improves solvency and reduces refinancing risk, enabling the company to fund growth and absorb shocks. Stronger equity supports strategic investments, partnership development, and provides flexibility for episodic cash needs over the medium term.
Healthcare Pharmacy Digital Platform ModelPlatform focus on pharmacy workflows creates structural advantages: recurring transactional touchpoints, potential network effects, and opportunities to embed services. Such a business model tends to produce sticky customers, multiple monetization paths, and long-term defensibility in healthcare workflows.
Bears Say
Large 2025 Cash-flow Outflow And VolatilityAn extreme negative cash-flow year signals material timing, working-capital or investment swings that undermine cash predictability. Such episodic drains can force external financing, constrain reinvestment, and raise execution risk during scaling, weakening long-term cash quality until consistency returns.
Volatile Leverage And Asset BaseSharp swings in debt and total assets reduce predictability of capital structure and suggest episodic financing or balance-sheet reconfiguration. This raises refinancing and liquidity uncertainty, complicates long-term planning, and increases the risk premium required by creditors and partners.
Inconsistent Cash Conversion And Limited Margin VisibilityIrregular FCF conversion versus earnings and missing recent margin detail reduce confidence in reported profitability quality. Without clear, consistent cash conversion and up-to-date margin disclosure, it's harder to assess sustainable earnings power and to forecast long-term free cash flow generation.
Kusurinomadoguchi, Inc. News
5592 FAQ
What was Kusurinomadoguchi, Inc.’s price range in the past 12 months?
Kusurinomadoguchi, Inc. lowest stock price was ¥2065.00 and its highest was ¥4685.00 in the past 12 months.
What is Kusurinomadoguchi, Inc.’s market cap?
Kusurinomadoguchi, Inc.’s market cap is ¥29.11B.
When is Kusurinomadoguchi, Inc.’s upcoming earnings report date?
Kusurinomadoguchi, Inc.’s upcoming earnings report date is Aug 14, 2026 which is tomorrow.
How were Kusurinomadoguchi, Inc.’s earnings last quarter?
Kusurinomadoguchi, Inc. released its earnings results on May 14, 2026. The company reported ¥73.87 earnings per share for the quarter, beating the consensus estimate of N/A by ¥73.87.
Is Kusurinomadoguchi, Inc. overvalued?
According to Wall Street analysts Kusurinomadoguchi, Inc.’s price is currently Overvalued.
Does Kusurinomadoguchi, Inc. pay dividends?
Kusurinomadoguchi, Inc. pays a Notavailable dividend of ¥40 which represents an annual dividend yield of 1.5%. See more information on Kusurinomadoguchi, Inc. dividends here
What is Kusurinomadoguchi, Inc.’s EPS estimate?
Kusurinomadoguchi, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kusurinomadoguchi, Inc. have?
Kusurinomadoguchi, Inc. has 11,459,482 shares outstanding.
What happened to Kusurinomadoguchi, Inc.’s price movement after its last earnings report?
Kusurinomadoguchi, Inc. reported an EPS of ¥73.87 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.51%.
Which hedge fund is a major shareholder of Kusurinomadoguchi, Inc.?
Currently, no hedge funds are holding shares in JP:5592
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kusurinomadoguchi, Inc.
Kusurinomadoguchi, Inc., established in 2004 and headquartered in Tokyo, Japan, develops and implements a diverse array of technology solutions specifically designed for pharmacies and the wider medical care sector throughout the country. Its comprehensive platform includes patient-facing services such as the EPARK drug counter, an online portal for locating and booking appointments at pharmacies, and the EPARK medicine notebook, which enables digital management of family prescriptions and reservation for medication dispensations. The company also offers a dedicated site facilitating telephone medical consultations for over-the-counter medicines, alongside a system allowing patients to select their preferred pharmacy for services, and provides online medication guidance as well as hospital-supported online consultations. For pharmacy operations and management, Kusurinomadoguchi delivers Health Tech Navi, an electronic medication history system, and the Care Daisy system, which integrates various recording tools and ICT devices. It further provides procurement solutions for pharmaceuticals, including a marketplace for dispensing pharmacies to efficiently buy and sell surplus or slow-moving inventory, extending to the management and acquisition of otherwise stagnant stock. The firm also features a centralized management system to streamline outpatient reception, appointment scheduling, and online medical treatments. Additionally, it offers Pharmacy Support, a robust customer relationship management (CRM) system tailored for engaging repeat patients, alongside specialized operational systems for dispensing pharmacies and a matching service connecting nursing care facilities with appropriate pharmacies.